Pearl Pharmaceuticals (01513) announced that on April 24, 2024, it cost approximately HK$7.3579 million to repurchase 28...
According to the Zhitong Finance App, Pearl Pharmaceutical (01513) announced that on April 24, 2024, it spent approximately HK$7.3579 million to repurchase 285,800 shares.